Date:   11/5/2014 9:35:15 PM ( 10 y ago)
Hits:   467
URL:   https://www.curezone.org/forums/fm.asp?i=2217249

here's a section from the article at http://www.trust.org/item/20140928132537-03qw4/?source=spotlight

GSK has said it is aiming to have 10,000 doses of its experimental [vaccine] shot by the end of the year, while Canada has given 800 vials of the NewLink candidate vaccine to the WHO, expected to yield at least 1,500 doses.

Most experts interviewed by Reuters favour the idea of the first doses going to frontline healthcare workers, since their exposure to risk is so high. Researchers could then compare infection rates among health workers who receive the vaccine to those working in regions still waiting for it.

Peter Piot, a co-discoverer of the Ebola virus in 1976 and now director of the London School of Hygiene and Tropical Medicine said that however complicated the ethics, reverting to the traditional years-long process of testing vaccines, and withholding them from West Africa until then, is not an option.

"It may be that without a vaccine, we can't really stop this epidemic," he said.
 

<< Return to the standard message view

fetched in 0.02 sec, referred by http://www.curezone.org/forums/fmp.asp?i=2217249